Patents by Inventor Mark W. Dudley

Mark W. Dudley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 8-substituted purines as selective adenosine receptor agents
    Patent number: 5208240
    Abstract: The present invention relates to certain novel 8-substituted purines as selective A.sub.1 -adenosine receptor antagonists which are useful in the treatment of patients suffering from Alzheimer's disease, congestive heart failure or pulmonary bronchoconstriction.
    Type: Grant
    Filed: March 12, 1991
    Date of Patent: May 4, 1993
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Norton P. Peet, Nelsen L. Lentz, Mark W. Dudley
  • Serotonin 5HT.sub.1A agonists
    Patent number: 5189179
    Abstract: The present invention is directed to a new class of serotonin 5HT.sub.1A agonists.
    Type: Grant
    Filed: July 30, 1991
    Date of Patent: February 23, 1993
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Ian A. McDonald, Ronald C. Bernotas, Mark W. Dudley, Jeffrey S. Sprouse
  • Phenoxy-heterocyclic compounds
    Patent number: 5134154
    Abstract: The present invention is directed to a new class of phenoxy-heterocyclic compounds and to their use as anti-depressants and as anxiolytics.
    Type: Grant
    Filed: March 5, 1991
    Date of Patent: July 28, 1992
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Jules Freedman, Mark W. Dudley